Loading...
Paxman AB (publ)
PXMBF•PNK
Healthcare
Medical - Devices
$3.50
$0.00(0.00%)
Paxman AB (publ) (PXMBF) Financial Performance & Income Statement Overview
Review Paxman AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.41%
↑ 20.41%
Operating Income Growth
165.54%
↑ 165.54%
Net Income Growth
382.55%
↑ 382.55%
Operating Cash Flow Growth
150.15%
↑ 150.15%
Operating Margin
12.24%
↑ 12.24%
Gross Margin
68.003%
↑ 68.003%
Net Profit Margin
8.14%
↑ 8.14%
ROE
11.67%
↑ 11.67%
ROIC
11.47%
↑ 11.47%
Paxman AB (publ) (PXMBF) Income Statement & Financial Overview
Review Paxman AB (publ)'s (PXMBF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $66.15M | $64.82M | $63.41M | $58.62M |
| Cost of Revenue | $20.09M | $20.66M | $52.81M | $51.22M |
| Gross Profit | $46.06M | $44.16M | $10.60M | $7.41M |
| Gross Profit Ratio | $0.70 | $0.68 | $0.17 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $16.88M | $15.16M |
| Operating Expenses | $39.06M | $35.67M | $34.10M | $33.08M |
| Total Costs & Expenses | $59.15M | $56.33M | $52.81M | $51.22M |
| Interest Income | $0.00 | $0.00 | $0.00 | $5.71M |
| Interest Expense | $316000.00 | $0.00 | $763000.00 | $0.00 |
| Depreciation & Amortization | $4.46M | $3.26M | $4.17M | $4.33M |
| EBITDA | $17.94M | $11.76M | $14.77M | $11.74M |
| EBITDA Ratio | $0.27 | $0.18 | $0.23 | $0.20 |
| Operating Income | $7.003M | $8.50M | $10.60M | $7.41M |
| Operating Income Ratio | $0.11 | $0.13 | $0.17 | $0.13 |
| Other Income/Expenses (Net) | $6.48M | -$3.44M | -$763000.00 | $5.71M |
| Income Before Tax | $13.49M | $5.06M | $9.84M | $13.11M |
| Income Before Tax Ratio | $0.20 | $0.08 | $0.16 | $0.22 |
| Income Tax Expense | $1.30M | $65000.00 | $21000.00 | -$4000.00 |
| Net Income | $12.18M | $5.00M | $9.82M | $13.11M |
| Net Income Ratio | $0.18 | $0.08 | $0.15 | $0.22 |
| EPS | $0.64 | $0.26 | $0.52 | $0.69 |
| Diluted EPS | $0.64 | $0.26 | $0.51 | $0.69 |
| Weighted Avg Shares Outstanding | $19.01M | $19.01M | $19.01M | $19.01M |
| Weighted Avg Shares Outstanding (Diluted) | $19.08M | $19.08M | $19.08M | $19.08M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan